微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.38% | -17.07% | -69.45% | 33/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 7.79% | -18.17% | 18.75% | 21/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 6.56% | -16.75% | 28.63% | 28/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 5.1% | -15.84% | 77.7% | 22/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 2.87% | -20.06% | -69.85% | 27/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 9.52% | 25.59% | 20.81% | 26/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 7.88% | 7.5% | 30.03% | 25/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 6.06% | 15.87% | 68.8% | 22/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 3.59% | 21.69% | -52.64% | 25/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 7.58% | 25.5% | 3.41% | 32/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 7.33% | 23.4% | 40.15% | 32/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 5.23% | 9.41% | 77.29% | 24/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.95% | 11.32% | -51.16% | 23/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 6.04% | 17.74% | 1.68% | 41/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 5.94% | 12.93% | 24.27% | 42/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 4.78% | -8.95% | 80.38% | 32/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.65% | -7.67% | -48.34% | 31/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 5.13% | 125.21% | -2.47% | 43/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 5.26% | 153.35% | 0.19% | 40/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 5.25% | -0.94% | 82.93% | 20/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 2.87% | -1.71% | 114.1% | 16/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | -20.35% | -314.89% | -106.39% | 65/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | -9.86% | -234.52% | -286.04% | 63/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 5.3% | 0.76% | 81.51% | 28/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 2.92% | 12.31% | -69.17% | 28/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 9.47% | 64.41% | 29.2% | 35/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 7.33% | 22.37% | 39.35% | 36/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 5.26% | 20.92% | 102.31% | 30/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 2.6% | 75.68% | -54.86% | 34/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 5.76% | -25.29% | -3.84% | 49/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 5.99% | 9.91% | 37.7% | 44/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 4.35% | 13.58% | 193.92% | 41/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 1.48% | -27.09% | -80.8% | 45/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 7.71% | 42.51% | 41.47% | 47/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 5.45% | 57.97% | 42.3% | 42/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 3.83% | 72.52% | 88.67% | 44/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 2.03% | 109.28% | -62.48% | 40/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 5.41% | 43.12% | 56.81% | 52/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 3.45% | -21.05% | 55.41% | 47/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 2.22% | -1.77% | 128.87% | 48/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 0.97% | -35.76% | -74.34% | 45/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |